Monocytes arise from stem cells in the bone marrow, enter the circulation and undergo final maturation to macrophages in peripheral tissue. Monocytes/macrophages are essential to wound healing as demonstrated by delayed or incomplete wound healing in animals depleted of monocytes. The inflammatory, proliferative and regenerative phases of wound healing require the participation of monocytes/macrophages either through their phagocytic or secretory function. Particularly important is the secretion of growth promoting factors which are capable of stimulating cellular proliferation and angiogenesis. Monocytes/macrophages may also support the growth of solid tumors through the production of paracrine and angiogenesis factors. Since the majority of monocytes/macrophages which infiltrate a wounded site or a solid tumor are recruited from the peripheral vasculature, factors which regulate monocyte chemotaxis are of considerable importance. The goal of this proposal is to study a monocyte chemoattractant, CF-O, produced by a cell line derived from an osteogenic sarcoma. The proposed studies include deducing the complete amino acid sequence of CF- O through characterization of the CF-O cDNA, studying transcriptional, translational, post-translational and secretory events in the production of CF-O, and describing its binding kinetics and stimulation of monocytes/macrophages. The constitutive synthesis of CF-O by a bone-derived cell line provides an opportunity to study a monocyte chemoattractant that may be important in osseous wound healing and in the growth of osseous tumors. This factor may provide insight into the potential control of monocyte chemotaxis by locally produced chemoattractants.

Agency
National Institute of Health (NIH)
Institute
National Institute of Dental & Craniofacial Research (NIDCR)
Type
Research Project (R01)
Project #
5R01DE007559-06
Application #
3221245
Study Section
Oral Biology and Medicine Study Section (OBM)
Project Start
1987-09-01
Project End
1992-06-30
Budget Start
1989-07-01
Budget End
1990-06-30
Support Year
6
Fiscal Year
1989
Total Cost
Indirect Cost
Name
Boston University
Department
Type
Schools of Dentistry/Oral Hygn
DUNS #
604483045
City
Boston
State
MA
Country
United States
Zip Code
02118
Alblowi, Jazia; Kayal, Rayyan A; Siqueira, Michelle et al. (2009) High levels of tumor necrosis factor-alpha contribute to accelerated loss of cartilage in diabetic fracture healing. Am J Pathol 175:1574-85
Behl, Yugal; Krothapalli, Padmaja; Desta, Tesfahun et al. (2009) FOXO1 plays an important role in enhanced microvascular cell apoptosis and microvascular cell loss in type 1 and type 2 diabetic rats. Diabetes 58:917-25
Graves, Dana T; Fine, Daniel; Teng, Yen-Tung A et al. (2008) The use of rodent models to investigate host-bacteria interactions related to periodontal diseases. J Clin Periodontol 35:89-105
Behl, Yugal; Krothapalli, Padmaja; Desta, Tesfahun et al. (2008) Diabetes-enhanced tumor necrosis factor-alpha production promotes apoptosis and the loss of retinal microvascular cells in type 1 and type 2 models of diabetic retinopathy. Am J Pathol 172:1411-8
Alikhani, Mani; Maclellan, Christine M; Raptis, Markos et al. (2007) Advanced glycation end products induce apoptosis in fibroblasts through activation of ROS, MAP kinases, and the FOXO1 transcription factor. Am J Physiol Cell Physiol 292:C850-6
Liu, R; Bal, H S; Desta, T et al. (2006) Diabetes enhances periodontal bone loss through enhanced resorption and diminished bone formation. J Dent Res 85:510-4
Leone, Cataldo W; Bokhadhoor, Haneen; Kuo, David et al. (2006) Immunization enhances inflammation and tissue destruction in response to Porphyromonas gingivalis. Infect Immun 74:2286-92
Alikhani, Mani; Alikhani, Zoubin; Graves, Dana T (2005) FOXO1 functions as a master switch that regulates gene expression necessary for tumor necrosis factor-induced fibroblast apoptosis. J Biol Chem 280:12096-102